Category Archives: Events

Latest From Events

Buzz of BIO to recognize the most innovative companies at the 2014 BIO Investor Forum™

BIF-BuzzofBIO-116x76

Nominations are now open for the Buzz of BIO at the 2014 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Early-stage companies looking for their next financing round or late-stage private companies hoping to make the valuable Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech CEOs Speak Out on JOBS Act Success

Biotech IPOs Infographic

Enacted in April 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to capital formation more attainable for small biotechnology companies, clearing the way for American innovation and ingenuity by removing bureaucratic hurdles and red tape to speed cures and medical breakthroughs to patients. The JOBS Act reached a major milestone last week, with the 100th company going public under its provisions. On October 7th at the 13th Annual BIO Investor Forum, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Partnering Trends in Latin America

BIO-One-On-One

If phonetics were the only driver, BRIC would be CRIB. But life sciences drug-related deal-making and partnering growth in Brazil and the rest of Latin America provide good reason to put the “B” in front. Traditional partnerships (i.e. excluding M&A and early venture funding) where a Latin American company served as the ‘seller’ or ‘out-licensor’ doubled per year from 2009/2010 to 2012. While there was a pullback in 2013, overall growth from 2009/2010 to 2013 Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

partnering1

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their hats into the ring. These three biotechs are targeting $175M in IPO cash, hoping to secure funding for oncology, pain, and rare diseases. In fact, there have been 96 IPOs since the passage of the JOBS Act in April of 2012. One important provision of the Act is the ability for emerging growth companies to conduct “testing the waters” meetings with Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The 2014 BIO International Convention Closes in San Diego

Gaslamp

The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world, concluded  today at the San Diego Convention Center with a record number of partnering meetings. Hosted by the Biotechnology Industry Organization (BIO), the event drew 15,667 industry leaders, including nearly 2,500 CEO’s, from 50 states and 70 countries. Read more on BIO.org

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,